Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>In prenatal care, accumulating evidences has demonstrated that whole‐exome sequencing (WES) expedites the genetic diagnosis of fetal structural anomalies. However, the clinical value of WES in the diagnosis of prenatal isolated congenital anomalies of the kidney and urinary tract (CAKUT) is unknown.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Forty‐one fetuses with unexplained isolated CAKUT, normal karyotype and negative chromosomal microarray analysis (CMA) results, underwent WES and were accordingly grouped as (a) Group 1: complex cases with bilateral renal abnormalities (N = 19); and (b) Group 2: cases with isolated unilateral fetal renal abnormalities (N = 22).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The detection rate of WES for pathogenic variants and incidental variants was 7.32% (3/41) and 2.4% (1/41), respectively. The three pathogenic variants were identified in the genes <i>ACTA2 </i> (multisystem smooth muscle dysfunction syndrome), <i>PKHD1 </i> (autosomal recessive form of polycystic kidney disease), and <i>PKD1 </i> (autosomal dominant polycystic kidney disease type 1). The incidental variants were detected in genes <i>PPM1D </i> (syndromic neurodevelopmental disorders). Furthermore, all above fetuses carrying pathogenic variants came from bilateral kidney anomalies. Thus, the detection rate was 0 for fetuses with unilateral fetal renal <i>abnormalities </i> and 15.7% (3/19) for bilateral renal abnormalities. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>This cohort shows that prenatal WES is a supplementary approach for the etiologic diagnosis of unexplained isolated CAKUT with negative CMA, especially for fetuses with bilateral renal abnormality.</p></section>

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the clinical value of whole - exome sequencing (WES) in prenatal diagnosis of isolated congenital anomalies of the kidney and urinary tract (CAKUT), especially in fetuses with negative chromosomal microarray analysis (CMA) results. Specifically, the study aims to explore whether WES can be used as a supplementary means to help identify unexplained genetic causes in these fetuses, especially for fetuses with bilateral renal anomalies. ### Research Background The incidence of congenital anomalies of the kidney and urinary tract (CAKUT) in prenatal ultrasound examinations is approximately 0.2%, and it accounts for 40% - 50% of end - stage renal disease (ESRD) in children worldwide and 7% of ESRD in adults. Studies have shown that genetic factors play an important role in the occurrence of CAKUT. Currently, more than 200 clinical syndromes are known to be associated with CAKUT, and approximately 40 single - gene mutations can lead to anomalies of the kidney and urinary tract. Although chromosomal microarray analysis (CMA) is currently recommended as the preferred genetic testing method for CAKUT fetuses, its detection rate is limited. Whole - exome sequencing (WES), as a high - throughput gene - testing technology, has been widely used in the clinical diagnosis of children's metabolic and neurodevelopmental disorders and has shown potential in prenatal diagnosis. However, the application effect and feasibility of WES in prenatal CAKUT diagnosis still need further study. ### Research Objectives 1. **Evaluate the clinical value of WES in prenatal diagnosis of isolated CAKUT**: Especially for fetuses with negative CMA results. 2. **Explore the diagnostic rate of WES in fetuses with bilateral renal anomalies**: Compare with fetuses with unilateral renal anomalies. 3. **Provide a basis for genetic counseling and pregnancy management**: Provide more accurate genetic counseling and pregnancy decision - making support for families through pathogenic and incidental variants detected by WES. ### Main Findings - **Overall diagnostic rate**: WES detected 3 pathogenic variants (7.32%) and 1 possible pathogenic variant (2.4%) in 41 isolated CAKUT fetuses. - **Bilateral renal anomalies**: All 3 pathogenic variants were found in fetuses with bilateral renal anomalies, with a diagnostic rate of 15.7% (3/19). - **Unilateral renal anomalies**: No pathogenic variants were detected, with a diagnostic rate of 0% (0/22). - **Genes of pathogenic variants**: The detected pathogenic variants are located in the *PKD1* (polycystic kidney disease type 1), *ACTA2* (multisystem smooth muscle dysfunction syndrome) and *PKHD1* (autosomal recessive polycystic kidney disease) genes respectively. - **Incidental variants**: One incidental variant is located in the *PPM1D* gene, which is related to neurodevelopmental disorders. ### Conclusion This study shows that WES can be used as a supplementary method for prenatal diagnosis of isolated CAKUT, especially in fetuses with bilateral renal anomalies and negative CMA results. The application of WES helps to improve the accuracy of genetic diagnosis and provides an important basis for genetic counseling and pregnancy management.

Molecular diagnostic in fetuses with isolated congenital anomalies of the kidney and urinary tract by whole‐exome sequencing

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Genetic diagnosis of common fetal renal abnormalities detected on prenatal ultrasound

Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China

Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China

Prenatal exome sequencing in fetuses with callosal anomalies

Genetic Spectrum of Congenital Anomalies of the Kidney and Urinary Tract in Chinese Newborn Genome Project

Prenatal diagnosis in the fetal hyperechogenic kidneys: assessment using chromosomal microarray analysis and exome sequencing

Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life

Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing

Contribution of Genomic Imbalance in Prenatal Congenital Anomalies of the Kidney and Urinary Tract: A Multi‐Center Cohort Study

Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies

Diagnostic Yield of Whole Exome Data in Fetuses Aborted for Conotruncal Malformations

[Whole Exome Sequencing Analysis of 37 Fetuses with Cardiac Abnormalities].

Whole‐genome sequencing in prenatally detected congenital malformations: prospective cohort study in clinical setting

Prenatal diagnosis and outcomes in fetuses with duplex kidney

Genomic insights into prenatal diagnosis of congenital heart defects: value of CNV-seq and WES in clinical practice

Promises, pitfalls and practicalities of prenatal whole exome sequencing